President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

ACADIA Pharmaceuticals has a rock solid balance sheet and advancing a couple of key drug candidates within its pipeline.

Kirkpatrick noted that the company continues to work on the development of its lead product, PF614, an extended-release oxycodone to treat severe pain, as well as its combination product, PF614-MPAR, ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands ...

UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced ...

Company reports $3.4 million in YCANTH revenue, reflective of increasing demand, following the dispensing of more than 10,000 applicator units in t ...

“It is hereby informed that in order to improve investor accessibility and participation, the BoD of Lucky Core Industries ...

Company had a strong start to 2025, emerging as an R&D-focused organization Exclusive license agreement with ...

A 446% gain in Palantir Technologies Inc. (PLTR) propelled Christy Anderson to a victory in the 2024-25 running of Dorfman’s Three-Stock Derby, an annual stock-picking contest. Anderson of Las Vegas ...

Stocks are mixed midday following upbeat inflation data, with the S&P 500 Index (SPX) breaking into positive territory for 2025 ...

Eton Pharmaceuticals, Inc ("Eton” or "the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported ...

Six weeks after the start of the stock market turmoil triggered by Trump's "Liberation Day" tariffs, markets are regaining confidence in the future, which still has a date, that of July when the pause ...